Ladenburg Thalmann Financial Services’s Madrigal Pharmaceuticals MDGL Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2019
Q4 | $4K | Hold |
47
| – | – | ﹤0.01% | 4865 |
|
|
2019
Q3 | $4K | Buy |
47
+20
| +74% | +$1.7K | ﹤0.01% | 4775 |
|
|
2019
Q2 | $3K | Sell |
27
-200
| -88% | -$22.2K | ﹤0.01% | 4881 |
|
|
2019
Q1 | $28K | Hold |
227
| – | – | ﹤0.01% | 3799 |
|
|
2018
Q4 | $25K | Hold |
227
| – | – | ﹤0.01% | 3729 |
|
|
2018
Q3 | $48K | Sell |
227
-525
| -70% | -$111K | ﹤0.01% | 3339 |
|
|
2018
Q2 | $88K | Hold |
752
| – | – | ﹤0.01% | 2828 |
|
|
2018
Q1 | $88K | Buy |
752
+700
| +1,346% | +$81.9K | ﹤0.01% | 2828 |
|
|
2017
Q4 | $5K | Hold |
52
| – | – | ﹤0.01% | 4517 |
|
|
2017
Q3 | $2K | Hold |
52
| – | – | ﹤0.01% | 4678 |
|
|
2017
Q2 | $1K | Hold |
52
| – | – | ﹤0.01% | 4743 |
|
|
2017
Q1 | $1K | Sell |
52
-28
| -35% | -$538 | ﹤0.01% | 4721 |
|
|
2016
Q4 | $1K | Hold |
80
| – | – | ﹤0.01% | 4675 |
|
|
2016
Q3 | $1K | Sell |
80
-1
| -1% | -$13 | ﹤0.01% | 4628 |
|
|
2016
Q2 | $0 | Hold |
81
| – | – | ﹤0.01% | 4797 |
|
|
2016
Q1 | $0 | Buy |
81
+28
| +53% | – | ﹤0.01% | 4749 |
|
|
2015
Q4 | $1K | Buy |
53
+43
| +430% | +$811 | ﹤0.01% | 4523 |
|
|
2015
Q3 | $1K | Hold |
10
| – | – | ﹤0.01% | 4431 |
|
|
2015
Q2 | $1K | Sell |
10
-57
| -85% | -$5.7K | ﹤0.01% | 4503 |
|
|
2015
Q1 | $5K | Buy |
67
+10
| +18% | +$746 | ﹤0.01% | 3979 |
|
|
2014
Q4 | $5K | Sell |
57
-2
| -3% | -$175 | ﹤0.01% | 3739 |
|
|
2014
Q3 | $6K | Hold |
59
| – | – | ﹤0.01% | 3328 |
|
|
2014
Q2 | $8K | Buy |
59
+2
| +4% | +$271 | ﹤0.01% | 3190 |
|
|
2014
Q1 | $9K | Hold |
57
| – | – | ﹤0.01% | 3014 |
|
|
2013
Q4 | $10K | Sell |
57
-57
| -50% | -$10K | ﹤0.01% | 2933 |
|
|
2013
Q3 | $25K | Buy |
+114
| New | +$25K | ﹤0.01% | 2296 |
|